Related Experiment Videos
[Clinical pharmacology and indications of meropenem in severe pediatric infection]
1Servicio de Farmacología Clínica, Clínica Universitaria, Facultad de Medicina, Universidad de Navarra, Pamplona.
Abstract:
The choice of an antibiotic for the treatment of a serious paediatric infection is generally a difficult problem. The arrival of Carbapenem resulted an important advance in the field of medicine due to its broad-spectrum, low incidence of resistances and good safety profile. Among Carbapenems, Meropenem introduction represents a progress because of its pharmacokinetics characteristics and blood-brain barrier penetration. Meropenem dosage depends on the patient weight, and the way of administration is potentially easier. Meropenem has been compared with the most used paediatric antimicrobial in controlled and randomised clinical trials, showing a high efficacy in the treatment of several infections (respiratory, urinary, intraabdominal, dermatological, septicemia) and in neutropenic and cystic fibrosis patients aged between one month and twelve years old. Meropenem is specially useful in the bacterial meningitis treatment because it penetrates into the cerebrospinal fluid of patients with inflamed meninges and reaches therapeutic concentrations, and because appearance of seizures is low. Adverse reactions produced by Meropenem show a poor incidence and its severity is usually mild. With regard to this characteristics, it can be concluded that Meropenem is an antimicrobial which efficacy and safety profiles guarantee its use in the treatment of severe paediatric infections.
Insights
Meropenem is a highly effective and safe antibiotic for treating serious pediatric infections, including meningitis. Its favorable pharmacokinetic profile and broad-spectrum activity make it a valuable option for children aged one month to twelve years.
Area of Science:
- Pediatric Infectious Diseases
- Antimicrobial Therapy
- Pharmacology
Background:
- Choosing antibiotics for severe pediatric infections is challenging.
- Carbapenems offer broad-spectrum activity, low resistance, and good safety.
- Meropenem, a carbapenem, has favorable pharmacokinetics and penetrates the blood-brain barrier.
Purpose of the Study:
- To evaluate the efficacy and safety of Meropenem in treating serious pediatric infections.
- To compare Meropenem with other commonly used pediatric antimicrobials.
Main Methods:
- Controlled and randomized clinical trials were conducted.
- Efficacy was assessed in various infections including respiratory, urinary, intra-abdominal, dermatological, and septicemia.
- Studies included neutropenic and cystic fibrosis patients aged one month to twelve years.
Main Results:
- Meropenem demonstrated high efficacy across multiple pediatric infection types.
- It showed particular utility in bacterial meningitis due to cerebrospinal fluid penetration and low seizure incidence.
- Adverse reactions were infrequent and generally mild.
Conclusions:
- Meropenem is a safe and effective antimicrobial for severe pediatric infections.
- Its pharmacokinetic properties, broad spectrum, and safety profile support its use in pediatric patients.
- Meropenem is a valuable therapeutic option, especially for bacterial meningitis in children.